Pfizer to invest $200m in Grange Castle biotech site

Pharmaceutical giant Pfizer is to invest $200 million (€147m) at its Grange Castle biotechnology manufacturing facility in Clondalkin, Co. Dublin.

The investment will enable Pfizer to introduce two new processing suites to the site and expand current production and product testing capabilities. During peak construction periods the project will generate up to 400 construction jobs.

Pfizer’s Grange Castle facility is one of the largest biotech manufacturing sites in the world and currently produces ...